(Bloomberg) — Sanofi entered a fresh round of exclusive negotiations to sell control of its consumer health unit to Clayton Dubilier & Rice after France secured commitments on local employment and ...
Clayton Dubilier & Rice is moving closer to clinching a $20 billion fundraising for its latest flagship buyout vehicle, people with knowledge of the matter said. The private equity firm has so far ...
CD&R downsizes OCS-Atalian transaction amid profit challenges Atalian bonds whipsaw in a sign of a challenging era for M&A It was set to be a slam-dunk €2.7 billion success story, bucking an otherwise ...
Roper Technologies, Inc. ROP recently entered into an agreement with Clayton, Dubilier & Rice, LLC (CD&R) to divest a majority of stake in its industrial businesses. The deal is valued at $2.6 billion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results